Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:07 PM
Ignite Modification Date:
2025-12-24 @ 9:07 PM
NCT ID:
NCT05330104
Eligibility Criteria:
Inclusion Criteria:
1. ≥ 45 years old
2. New cancer diagnosis other than a primary brain tumor
3. A taxane and/or platinum chemotherapy agent has been prescribed as part of the treatment regimen for cancer.
4. English speaking
5. Able to see, hear, speak (with or without assistive devices)
6. Able to walk without an assistive device - for example: cane, walker, walking stick(s) at the start of cancer treatment
7. Able to provide own transportation to study visits
8. Willing and able to commit to symptom tracking three times weekly via mEMA for up to 9 months.
9. Owns a smartphone with one of the following operating system versions:
iOS 8.0 - 8.4, 9.0 - 9.3, 10.0 - 10.3, 12, 13.3 or later Android 7.0 - 7.1.2, 8.0 - 8.1.0, 9, 10 or later
10. Agree to use personal smartphone to download the mEMA application and respond to application notifications.
Exclusion Criteria:
1. Individuals who started their chemotherapy regimen greater than 4 weeks prior to study enrollment.
2. Individuals being treated for a primary brain tumor
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT05330104
Study Brief:
Protocol Section:
NCT05330104